NEW YORK CITY, NY / ACCESSWIRE / January 6, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Viking Therapeutics, Inc. ("Viking" or the "Company") (NASDAQ:VKTX). Such investors ...

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...

Summit Partners, a leading growth-focused investment firm, is pleased to announce the addition of Ricardo Gonzalez as a Partner on the firm’s Growth Products & Services team. Mr. Gonzalez brings more ...

Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.

Topical antifungals, although often effective, are being discouraged in the early treatment of seborrheic dermatitis now that ...

Experts propose potential workarounds for obstacles to wider use of combined clinics and personalized medicine for ...

The U.S. Surgeon General issued an advisory that alcohol consumption is a leading preventable cause of cancer, calling for an ...

As the weight-loss drugs become more popular, consumer habits are starting to reflect changing consumption behavior, ...

Stock futures rose, with Nasdaq-100 leading the gains, rising more than 0.5%. The 10-year Treasury yield ticked lower. It settled at 4.577% Tuesday to close out 2024. Bitcoin traded above $96,000, ...

BlossomHill Therapeutics, Inc., a clinical-stage biotechnology company focused on the design and development of small molecule medicines for treating cancer and autoimmune diseases, today announced ...

With new treatments in neurology, and more in development in cardiology and autoimmune diseases, precision medicine is moving beyond cancer and rare disease.

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 492.13% and ...